This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNally, L. M.
Right arrow Articles by McNally, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNally, L. M.
Right arrow Articles by McNally, M. T.

Next Article 

Mol Cell Biol, June 1998, p. 3103-3111, Vol. 18, No. 6
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

An RNA Splicing Enhancer-Like Sequence Is a Component of a Splicing Inhibitor Element from Rous Sarcoma Virus

Lisa M. McNally and Mark T. McNally*

Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226

Received 5 January 1998/Returned for modification 18 February 1998/Accepted 10 March 1998

The accumulation in infected cells of large amounts of unspliced viral RNA for use as mRNA and genomic RNA is a hallmark of retrovirus replication. The negative regulator of splicing (NRS) is a long cis-acting RNA element in Rous sarcoma virus that contributes to unspliced RNA accumulation through splicing inhibition. One of two critical sequences located in the NRS 3' region resembles a minor class 5' splice site and is required for U11 small nuclear ribonucleoprotein (snRNP) binding to the NRS. The second is a purine-rich region in the 5' half that interacts with the splicing factor SF2/ASF. In this study we investigated the possibility that this purine-rich region provides an RNA splicing enhancer function required for splicing inhibition. In vitro, the NRS acted as a potent, orientation-dependent enhancer of Drosophila doublesex pre-mRNA splicing, and enhancer activity mapped to the purine-rich domain. Analysis of a number of site-directed and deletion mutants indicated that enhancer activity was diffusely located throughout a 60-nucleotide area but only the activity associated with a short region previously shown to bind SF2/ASF correlated with efficient splicing inhibition. The significance of the enhancer activity to splicing inhibition was demonstrated by using chimeras in which two authentic enhancers (ASLV and FP) were substituted for the native NRS purine region. In each case, splicing inhibition in transfected cells was restored to levels approaching that observed for the NRS. The observation that a nonfunctional version of the FP enhancer (FPD) that does not bind SF2/ASF also fails to block splicing when paired with the NRS 3' region supports the notion that SF2/ASF binding to the NRS is relevant, but other SR proteins may substitute if an appropriate binding site is supplied. Our results are consistent with a role for the purine region in facilitated snRNP binding to the NRS via SF2/ASF.


* Corresponding author. Mailing address: Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226. Phone: (414) 456-8749. Fax: (414) 456-6535. E-mail: mtm{at}mcw.edu.


Mol Cell Biol, June 1998, p. 3103-3111, Vol. 18, No. 6
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Maciolek, N. L., McNally, M. T. (2007). Serine/Arginine-Rich Proteins Contribute to Negative Regulator of Splicing Element-Stimulated Polyadenylation in Rous Sarcoma Virus. J. Virol. 81: 11208-11217 [Abstract] [Full Text]  
  • Buratti, E., Stuani, C., De Prato, G., Baralle, F. E. (2007). SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer. Nucleic Acids Res 35: 4359-4368 [Abstract] [Full Text]  
  • Wilusz, J. E., Beemon, K. L. (2006). The Negative Regulator of Splicing Element of Rous Sarcoma Virus Promotes Polyadenylation. J. Virol. 80: 9634-9640 [Abstract] [Full Text]  
  • McNally, L. M., Yee, L., McNally, M. T. (2006). Heterogeneous Nuclear Ribonucleoprotein H Is Required for Optimal U11 Small Nuclear Ribonucleoprotein Binding to a Retroviral RNA-processing Control Element: IMPLICATIONS FOR U12-DEPENDENT RNA SPLICING. J. Biol. Chem. 281: 2478-2488 [Abstract] [Full Text]  
  • Giles, K. E., Beemon, K. L. (2005). Retroviral Splicing Suppressor Sequesters a 3' Splice Site in a 50S Aberrant Splicing Complex. Mol. Cell. Biol. 25: 4397-4405 [Abstract] [Full Text]  
  • McNally, L. M., Yee, L., McNally, M. T. (2004). Two Regions Promote U11 Small Nuclear Ribonucleoprotein Particle Binding to a Retroviral Splicing Inhibitor Element (Negative Regulator of Splicing). J. Biol. Chem. 279: 38201-38208 [Abstract] [Full Text]  
  • CABELLO-VILLEGAS, J., GILES, K. E., SOTO, A. M., YU, P., MOUGIN, A., BEEMON, K. L., WANG, Y.-X. (2004). Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor. RNA 10: 1388-1398 [Abstract] [Full Text]  
  • Polony, T. S., Bowers, S. J., Neiman, P. E., Beemon, K. L. (2003). Silent Point Mutation in an Avian Retrovirus RNA Processing Element Promotes c-myb-Associated Short-Latency Lymphomas. J. Virol. 77: 9378-9387 [Abstract] [Full Text]  
  • Fairbrother, W. G., Yeh, R.-F., Sharp, P. A., Burge, C. B. (2002). Predictive Identification of Exonic Splicing Enhancers in Human Genes. Science 297: 1007-1013 [Abstract] [Full Text]  
  • Simard, M. J., Chabot, B. (2002). SRp30c Is a Repressor of 3' Splice Site Utilization. Mol. Cell. Biol. 22: 4001-4010 [Abstract] [Full Text]  
  • Fogel, B. L., McNally, L. M., McNally, M. T. (2002). Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element. Nucleic Acids Res 30: 810-817 [Abstract] [Full Text]  
  • Simard, M. J., Chabot, B. (2000). Control of hnRNP A1 Alternative Splicing: an Intron Element Represses Use of the Common 3' Splice Site. Mol. Cell. Biol. 20: 7353-7362 [Abstract] [Full Text]  
  • Bourgeois, C. F., Popielarz, M., Hildwein, G., Stevenin, J. (1999). Identification of a Bidirectional Splicing Enhancer: Differential Involvement of SR Proteins in 5' or 3' Splice Site Activation. Mol. Cell. Biol. 19: 7347-7356 [Abstract] [Full Text]  
  • Frilander, M. J., Steitz, J. A. (1999). Initial recognition of U12-dependent introns requires both U11/5' splice-site and U12/branchpoint interactions. Genes Dev. 13: 851-863 [Abstract] [Full Text]  
  • McNally, L. M., McNally, M. T. (1999). U1 Small Nuclear Ribonucleoprotein and Splicing Inhibition by the Rous Sarcoma Virus Negative Regulator of Splicing Element. J. Virol. 73: 2385-2393 [Abstract] [Full Text]  
  • Cook, C. R., McNally, M. T. (1999). Interaction between the Negative Regulator of Splicing Element and a 3' Splice Site: Requirement for U1 Small Nuclear Ribonucleoprotein and the 3' Splice Site Branch Point/Pyrimidine Tract. J. Virol. 73: 2394-2400 [Abstract] [Full Text]  
  • Kan, J. L.C., Green, M. R. (1999). Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. Genes Dev. 13: 462-471 [Abstract] [Full Text]  
  • Fogel, B. L., McNally, M. T. (2000). A Cellular Protein, hnRNP H, Binds to the Negative Regulator of Splicing Element from Rous Sarcoma Virus. J. Biol. Chem. 275: 32371-32378 [Abstract] [Full Text]  
  • Pagani, F., Buratti, E., Stuani, C., Romano, M., Zuccato, E., Niksic, M., Giglio, L., Faraguna, D., Baralle, F. E. (2000). Splicing Factors Induce Cystic Fibrosis Transmembrane Regulator Exon 9 Skipping through a Nonevolutionary Conserved Intronic Element. J. Biol. Chem. 275: 21041-21047 [Abstract] [Full Text]